Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Baicalin may help treat severe drug-induced skin reactions.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

Erlotinib can cause excessive eyelash growth.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Compound 7p shows strong potential as an anticancer agent.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Brodalumab is more effective than ustekinumab in treating psoriasis.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Some drugs for inflammation may cause psoriasis-like hair loss.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.